Robert Hamilton

Dr. Robert Hamilton


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2014 in Allergy, Asthma & Clinical Immunology
Verified
Journal Article
Open access
PDF file
PBPhilippe Bégin
Philippe Bégin
TDTina Dominguez
Tina Dominguez
SWShruti P Wilson
Shruti P Wilson
LBLiane Bacal
Liane Bacal
AMAnjuli Mehrotra
Anjuli Mehrotra
Kari NadeauKari Nadeau
Kari Nadeau
Up to 30% of patients with food allergies have clinical reactivity to more than one food allergen. Although there is currently no cure, oral immunotherapy (OIT) is under investigation. Pilot data have shown that omalizumab may hasten the ability to tolerate over 4 g of food allergen protein.

15 January 2014 in Allergy, Asthma & Clinical Immunology
Verified
Journal Article
Open access
PDF file
PBPhilippe Bégin
Philippe Bégin
LWLisa C Winterroth
Lisa C Winterroth
TDTina Dominguez
Tina Dominguez
SWShruti P Wilson
Shruti P Wilson
LBLiane Bacal
Liane Bacal
Kari NadeauKari Nadeau
Kari Nadeau
Thirty percent of children with food allergy are allergic to more than one food. Previous studies on oral immunotherapy (OIT) for food allergy have focused on the administration of a single allergen at the time. This study aimed at evaluating the safety of a modified OIT protocol using multiple foods at one time.

1 August 2005 in Journal of Immunological Methods
Verified
Journal Article
Closed access
RHRobert Hamilton
Robert Hamilton
GMGregory V. Marcotte
Gregory V. Marcotte
SSSarbjit S. Saini
Sarbjit S. Saini

1 April 2006 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
RHRobert Hamilton
Robert Hamilton

1 August 2004 in Current Opinion in Allergy and Clinical Immunology
Verified
Journal Article
Closed access
RHRobert Hamilton
Robert Hamilton
This review overviews advances from mid-2002 to the present in the validation and performance methods used in the diagnosis of Hymenoptera venom-induced immediate-type hypersensitivity. The general diagnostic algorithm for insect sting allergy is initially discussed with an examination of the AAAAI's 2003 revised practice parameter guidelines. Changes as a result of a greater recognition of skin test negative systemic reactors include repeat analysis of all testing and acceptance of serology as a complementary diagnostic test to the skin test. Original data examining concordance of venom-specific IgE results produced by the second-generation Pharmacia CAP System with the Johns Hopkins University radioallergosorbent test are presented. Diagnostic performance of honeybee venom-specific IgE assays used in clinical laboratories in North America is discussed using data from the Diagnostic Allergy Proficiency Survey conducted by the College of American Pathologists. Validity of venom-specific IgE antibody in postmortem blood specimens is demonstrated. The utility of alternative in-vivo (provocation) and in-vitro (basophil-based) diagnostic testing methods is critiqued. This overview supports the following conclusions. Improved practice parameter guidelines include serology and skin test as complementary in supporting a positive clinical history during the diagnostic process. Data are provided which support the analytical performance of commercially available venom-specific IgE antibody serology-based assays. Intentional sting challenge in-vivo provocation, in-vitro basophil flow cytometry (CD63, CD203c) based assays, and in-vitro basophil histamine and sulfidoleukotriene release assays have their utility in the study of difficult diagnostic cases, but their use will remain as supplementary, secondary diagnostic tests.

1 November 2014 in Clinical Immunology
Verified
Journal Article
Closed access
PFPamela A. Frischmeyer-Guerrerio
Pamela A. Frischmeyer-Guerrerio
CKCorinne A. Keet
Corinne A. Keet
AGAnthony L. Guerrerio
Anthony L. Guerrerio
KCKristin L. Chichester
Kristin L. Chichester
ABAnja P. Bieneman
Anja P. Bieneman
JSJohn T. Schroeder
John T. Schroeder